Literature DB >> 31592079

The Gastroenterologist's Guide to Preventive Management of Compensated Cirrhosis.

Akshay Shetty1, Jung Jun Yum1, Sammy Saab1.   

Abstract

Despite advances in medical care, the prevalence and mortality associated with cirrhosis continue to rise. The majority of medical care and physician efforts are devoted to the management of decompensated cirrhosis and its complications of gastrointestinal hemorrhage, hepatic encephalopathy, and ascites; however, limited efforts are placed on the medical management of compensated cirrhosis. Patients with compensated cirrhosis carry a higher survival rate, and, when diagnosed early, may be screened for future decompensation. When possible, these patients can be treated for their underlying disease to prevent disease progression and avoid the need for liver transplantation. This article reviews the importance of early diagnosis, outpatient management of compensated cirrhosis, early screening for potential decompensation, and patient education.
Copyright © 2019, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  Compensated cirrhosis; gastroesophageal varices; hepatocellular carcinoma; malnutrition; patient education; polypharmacy

Year:  2019        PMID: 31592079      PMCID: PMC6771034     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  50 in total

Review 1.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

2.  Alcohol Use in Patients with Chronic Liver Disease.

Authors:  Daniel Fuster; Jeffrey H Samet
Journal:  N Engl J Med       Date:  2018-12-27       Impact factor: 91.245

3.  Oral health in patients with liver cirrhosis.

Authors:  Lea L Grønkjær; Hendrik Vilstrup
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-07       Impact factor: 2.566

Review 4.  Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.

Authors:  Lise Lotte Gluud; Aleksander Krag
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

5.  Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).

Authors:  Francoise Degos; Paul Perez; Bruno Roche; Amel Mahmoudi; Julien Asselineau; Hélène Voitot; Pierre Bedossa
Journal:  J Hepatol       Date:  2010-08-14       Impact factor: 25.083

Review 6.  Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Authors:  Samir Gupta; Stephen Bent; Jeffrey Kohlwes
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

7.  Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis.

Authors:  Motoh Iwasa; Kazuko Iwata; Nagisa Hara; Ayana Hattori; Masumi Ishidome; Noriko Sekoguchi-Fujikawa; Rumi Mifuji-Moroka; Ryosuke Sugimoto; Naoki Fujita; Yoshinao Kobayashi; Yoshiyuki Takei
Journal:  Nutrition       Date:  2013 Nov-Dec       Impact factor: 4.008

8.  Influenza A/H1/N1/09 infection in patients with cirrhosis has a poor outcome: a case series.

Authors:  Chinmaya Kumar Bal; Vikram Bhatia; Sachin Kumar; Deepak Saini; Vikas Khillan; Ekta Gupta; Neha Rathor; Ashok Choudhury; Naveen Kumar; Ripu Daman; Shiv Kumar Sarin
Journal:  Indian J Gastroenterol       Date:  2014-01-29

9.  Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.

Authors:  Nabihah Tayob; Anna S F Lok; Kim-Anh Do; Ziding Feng
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-07       Impact factor: 11.382

10.  Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.

Authors:  Amit G Singal; Anjana Pillai; Jasmin Tiro
Journal:  PLoS Med       Date:  2014-04-01       Impact factor: 11.069

View more
  3 in total

1.  Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study.

Authors:  Joshua P Kronenfeld; Emily L Ryon; David Goldberg; Rachel M Lee; Adam Yopp; Annie Wang; Ann Y Lee; Sommer Luu; Cary Hsu; Eric Silberfein; Maria C Russell; Alan S Livingstone; Nipun B Merchant; Neha Goel
Journal:  Ann Surg Oncol       Date:  2020-09-25       Impact factor: 5.344

2.  Rising Healthcare Costs and Utilization among Young Adults with Cirrhosis in Ontario: A Population-Based Study.

Authors:  Jeffrey B Ames; Maya Djerboua; Norah A Terrault; Christopher M Booth; Jennifer A Flemming
Journal:  Can J Gastroenterol Hepatol       Date:  2022-03-09

3.  Cutoff Values for Serum Ferritin in Predicting Cirrhosis Severity due to Cholestatic Jaundice in Vietnamese Children.

Authors:  Ha-Van Thieu; Thach Binh Minh; Tran-Thi Khanh Tuong; Nguyen Minh Duc
Journal:  Med Arch       Date:  2022-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.